Steve Bryson is a science writer for Pulmonary Hypertension News with a PhD in biochemistry. He covers the latest news and information on a variety of pulmonary hypertension topics.| Pulmonary Hypertension News
Cereno Scientific reported a successful meeting with the FDA on the design of a future clinical trial for its PAH therapy candidate CS1.| Pulmonary Hypertension News